VentureBeat

Xcell Biosciences Announces $12 Million Series A Funding Round

Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led by HBM Genomics along with the continued participation of all ...
PharmiWeb

Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies

SAN FRANCISCO, June 24, 2025 – Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with ...
VentureBeat

Xcell Biosciences Announces New Emphasis Towards Immunotherapy Markets and Expands Leadership Team

Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing ...
Yahoo Finance

Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning

SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and Culture ...
Business Wire

NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Improve and Accelerate Gene Therapy Development

LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering tools for efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, ...
Yahoo Finance

Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow

MELBOURNE, Australia & PERTH, Australia, March 25, 2025--(BUSINESS WIRE)--Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell ...